Long-term benefit of immunotherapy in metastatic non-small cell lung cancer: the tale of the tail

Ayse Ece Cali Daylan, Balazs Halmos

Research output: Contribution to journalComment/debate

5 Scopus citations
Original languageEnglish
Pages (from-to)1636-1642
Number of pages7
JournalTranslational Lung Cancer Research
Volume12
Issue number7
DOIs
StatePublished - Jul 2023

Keywords

  • Immunotherapy
  • metastatic
  • non-small cell lung cancer (NSCLC)
  • pembrolizumab

Cite this